Modulation of tamoxifen-induced hepatotoxicity by tamoxifen–phospholipid complex
Journal of Pharmacy and Pharmacology2015Vol. 67(9), pp. 1198–1206
Citations Over TimeTop 10% of 2015 papers
Abstract
Data of the present study suggests that phospholipid may prove as a useful component of combination therapy in cancer patients under the TMX treatment regimen.
Related Papers
- → Tissue distribution of 4-hydroxy-N-desmethyltamoxifen and tamoxifen-N-oxide(2012)34 cited
- → Sensitivity and insensitivity of breast cancer to tamoxifen(1990)19 cited
- → Tamoxifen stimulates in vivo growth of drug-resistant estrogen receptor-negative breast cancer(1993)11 cited
- → Reduced tamoxifen accumulation is not associated with stimulated growth in tamoxifen resistance(1994)4 cited
- → DETERMINING QUALITY REQUIREMENTS AT THE UNIVERSITIES TO IMPROVE THE QUALITY OF EDUCATION(2018)